Breaking News

The Ultimate End of Life Planning Checklist

With Pillar, you can get ahead of that by proactively planning. Take things one day at a time so you can be less stressed in the future and focus more on the real things that matter – the person you love.

Philips PET/CT Scanner Vereos, with Ambient Experience Installed at Phoenix Children’s Hospital: To Be Used for Oncological Exams to Help Define the Stage to Which a Cancer Has Developed...

“Working with Philips, we managed to help the children, and also their parents, achieve a sustained sense of calm during the entire PET/CT imaging procedure while enabling faster image acquisition, faster time-to-results, and reduced need for anesthesia,” said Dianna M. E. Bardo MD, Vice-Chair Clinical Development Radiology at Phoenix Children’s Hospital.

Canon Medical Offers New Liver Reporting Tool for Ultrasound

To help easily and accurately determine cut off values, Canon Medical Systems USA, Inc.’s premium AplioTM i-series ultrasound platform is now available with software to display the calculated measurement averages from multiple samples of the liver, customizable based on the “Rule of Four.”

Julianne Averill Strong Track Record Moves Her Into Leadership Position at Alveo Technologies

Julianne Averill, CPA, as Chief Financial Officer. In this role, Ms. Averill will be responsible for leading all financial operations and implementing key business strategies to accelerate Alveo’s growth as the company advances its be.well™ platform, a point-of-care and at-home diagnostic tool currently under development.

“Julianne’s strong track record of driving results and accelerating growth comes at a critical time as the U.S. enters the twindemic COVID+flu season,” said Ron Chiarello, Ph.D., Chairman, CEO and Founder of Alveo. “As Alveo continues its initiative of bringing accurate, at-home testing solutions to market, Julianne’s strong financial expertise will be a valuable asset to the leadership team, ensuring we remain poised for long-term success.”

Julianne Averill brings over 18 years of leadership experience in the life sciences, technology/SaaS, and digital health fields as well as has participated in or led over $2B in successful strategic financing and M&A initiatives. Most recently, she served as Vice President of Finance for BlackThorn Therapeutics, driving strategic growth initiatives and investment strategies. Ms. Averill has held leadership roles at Manifest MedEx and Starwood Waypoint Residential Trust, where she successfully improved financial operations to support long-term company growth. She also served as an audit manager at Deloitte, working with various Fortune 500 and international entities in the consumer business and life sciences industries.

“I was instantly drawn to Alveo’s vision of putting an affordable, rapid at-home diagnostic tool for infectious diseases into the hands of consumers worldwide,” said Ms. Averill. “Alveo has a strong leadership team, a unique solution, and tremendous potential. I am thrilled to be joining the company at this exciting stage of its development. I look forward to leveraging my experience to help drive growth at Alveo as it continues on the trajectory of transforming the way infectious diseases are detected and managed.”

 

Latest Posts

Segmed Raises $2 Million Seed Round: Financing led by Blumberg Capital

"We aim to aggregate and leverage larger and more representative datasets for use in medical AI to ultimately deliver better healthcare around the world," said Cailin Hardell, co-founder, and CEO, Segmed.

The Ultimate End of Life Planning Checklist

With Pillar, you can get ahead of that by proactively planning. Take things one day at a time so you can be less stressed in the future and focus more on the real things that matter – the person you love.

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.